GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4

GW Pharmaceuticals (NASDAQ: GWPH) has released what is very possibly its final earnings report as an independent company.On Tuesday, the maker of drugs derived from cannabis published its fourth-quarter results, which revealed that it earned $148 million in revenue for the periodRead MoreMarketsMarkets Feed